Found: 10
Select item for more details and to access through your institution.
Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07466-z
- By:
- Publication type:
- Article
Author Correction: Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Reduced-Dose Rivaroxaban Is Associated with Lower All-Cause Mortality in Older Patients with Nonvalvular Atrial Fibrillation.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 20, p. 6686, doi. 10.3390/jcm12206686
- By:
- Publication type:
- Article
Relations between baseline burden, maximum duration, and relative reduction of atrial fibrillation: Insights from continuous monitoring in rhythm control.
- Published in:
- Journal of Cardiovascular Electrophysiology, 2019, v. 30, n. 2, p. 178, doi. 10.1111/jce.13824
- By:
- Publication type:
- Article
Clinical impacts of sacubitril/valsartan on patients eligible for cardiac resynchronization therapy.
- Published in:
- ESC Heart Failure, 2022, v. 9, n. 6, p. 3825, doi. 10.1002/ehf2.14107
- By:
- Publication type:
- Article
Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1204, doi. 10.1002/ehf2.13182
- By:
- Publication type:
- Article
Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial Fibrillation.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 4, p. 459, doi. 10.1007/s40256-020-00454-6
- By:
- Publication type:
- Article
Closed loop stimulation helps with weaning from chronotropic incompetence-related ventilator dependence.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Duration of Heart Failure With Reduced Ejection Fraction Associated With Electrocardiographic Outcomes Before and After Sacubitril/Valsartan.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 2022, v. 27, p. 1, doi. 10.1177/10742484221107799
- By:
- Publication type:
- Article
Exploratory Evaluation of Rhythm Control by Dronedarone in Combination With Low-Dose Rivaroxaban, Warfarin, Antiplatelet, or None of the Antithrombotic Therapy in High-Risk Patients With Non-Permanent Atrial Fibrillation: A Retrospective Cohort Study.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2021, v. 27, p. 1, doi. 10.1177/10760296211052968
- By:
- Publication type:
- Article